Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12


Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.

Sun HY, Sheng WH, Tsai MS, Lee KY, Chang SY, Hung CC.

World J Gastroenterol. 2014 Oct 28;20(40):14598-614. doi: 10.3748/wjg.v20.i40.14598. Review.


Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis.

Price H, Dunn D, Pillay D, Bani-Sadr F, de Vries-Sluijs T, Jain MK, Kuzushita N, Mauss S, Núñez M, Nüesch R, Peters M, Reiberger T, Stephan C, Tan L, Gilson R.

PLoS One. 2013 Jul 10;8(7):e68152. doi: 10.1371/journal.pone.0068152. Print 2013. Review.


Safety of coitally administered tenofovir 1% gel, a vaginal microbicide, in chronic hepatitis B virus carriers: results from the CAPRISA 004 trial.

Baxter C, Yende-Zuma N, Tshabalala P, Abdool Karim Q, Abdool Karim SS.

Antiviral Res. 2013 Sep;99(3):405-8. doi: 10.1016/j.antiviral.2013.06.019. Epub 2013 Jul 4.


A Review of the 2010 WHO Adult Antiretroviral Therapy Guidelines: Implications and Realities of These Changes for Zambia.

Patel DM, Moyo C, Bositis CM.

Med J Zambia. 2010;37(2):118-124. No abstract available.


Antiretroviral therapy in Indian setting: when & what to start with, when & what to switch to?

Kumarasamy N, Patel A, Pujari S.

Indian J Med Res. 2011 Dec;134(6):787-800. doi: 10.4103/0971-5916.92626. Review.


Prevalence of hepatitis B and hepatitis C coinfections in an adult HIV centre population in Gaborone, Botswana.

Patel P, Davis S, Tolle M, Mabikwa V, Anabwani G.

Am J Trop Med Hyg. 2011 Aug;85(2):390-4. doi: 10.4269/ajtmh.2011.10-0510.


Combination Therapy for Chronic Hepatitis B: Current Indications.

Paul N, Han SH.

Curr Hepat Rep. 2011 Jun;10(2):98-105. Epub 2011 Feb 19.


Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings.

Peterson K, Jallow S, Rowland-Jones SL, de Silva TI.

AIDS Res Treat. 2011;2011:463704. doi: 10.1155/2011/463704. Epub 2011 Feb 9.


Development of fatal acute liver failure in HIV-HBV coinfected patients.

Anderson AM, Mosunjac MB, Palmore MP, Osborn MK, Muir AJ.

World J Gastroenterol. 2010 Aug 28;16(32):4107-11.


Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption.

Dore GJ, Soriano V, Rockstroh J, Kupfer B, Tedaldi E, Peters L, Neuhaus J, Puoti M, Klein MB, Mocroft A, Clotet B, Lundgren JD; SMART INSIGHT study group.

AIDS. 2010 Mar 27;24(6):857-65. doi: 10.1097/QAD.0b013e328334bddb.


Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.

Menne S, Butler SD, George AL, Tochkov IA, Zhu Y, Xiong S, Gerin JL, Cote PJ, Tennant BC.

Antimicrob Agents Chemother. 2008 Oct;52(10):3617-32. doi: 10.1128/AAC.00654-08. Epub 2008 Aug 1.

Supplemental Content

Support Center